ABT vs NVDA · P/E 25, rev $44.33B vs P/E 58, rev $215.94B
Abbott Laboratories (ABT) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jen-Hsun Huang.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported NVDA revenue for 2026-01-25 was $215.94B. Net income was $120.07B. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the ABT and NVDA stock pages for the full models.
Not investment advice.